Want to see IN:BAJAJCON full AI Analyst Report?
Top Page
Bajaj Consumer Care Limited
(BAJAJCON)
Select Model
Select Model
Rating:73Outperform
Price Target:
₹413.00
▼(-25.06% Downside)
Action:Reiterated
Date:10/16/26
Score is primarily supported by strong financial quality (very low leverage, healthy returns, and improved 2026 cash generation) and a constructive earnings call emphasizing sustained growth drivers (brand reinvigoration and distribution expansion). The main constraints are weak technical momentum (below key moving averages with negative MACD) and a moderately demanding P/E (~24.7) without dividend yield data to offset valuation risk.
Positive Factors
Conservative balance sheet
Very low leverage gives Bajaj Consumer Care substantial financial flexibility to fund brand investment, distribution expansion, and working-capital needs without heavy debt-service pressure. Healthy returns on equity also indicate that the existing capital base is being used productively.
Negative Factors
Margin compression
Although profitability remains solid, margins have declined materially from earlier years, indicating that prior earnings quality has not been fully preserved. Continued compression could reduce the cash available for advertising, innovation, and distribution investment even if revenue growth remains healthy.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
Very low leverage gives Bajaj Consumer Care substantial financial flexibility to fund brand investment, distribution expansion, and working-capital needs without heavy debt-service pressure. Healthy returns on equity also indicate that the existing capital base is being used productively.
Read all positive factors
Bajaj Consumer Care Limited (BAJAJCON) vs. iShares MSCI India ETF (INDA)
Market Cap
₹48.53B
Dividend Yield3.77%
Average Volume (3M)50.92K
Price to Earnings (P/E)19.5
Beta (1Y)1.08
Revenue Growth28.55%
EPS Growth92.82%
CountryIN
Employees506
SectorGeneral
Sector StrengthN/A
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)18.98
Shares Outstanding131,129,470
10 Day Avg. Volume73,352
30 Day Avg. Volume50,921
Financial Highlights & Ratios
PEG Ratio0.43
Price to Book (P/B)6.17
Price to Sales (P/S)4.00
P/FCF Ratio24.85
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)20.08
Revenue Forecast (FY)₹13.77B
Bajaj Consumer Care Limited Business Overview & Revenue Model
Company Description
Bajaj Consumer Care Limited, a company founded in 1953 and based in Udaipur, India, operates as a key manufacturer and global distributor of personal grooming and hygiene products. Its extensive product range caters to various needs, including hai...
How the Company Makes Money
Bajaj Consumer Care Limited makes money primarily by manufacturing and selling branded FMCG products, with the largest contribution coming from its hair oil portfolio (notably Bajaj Almond Drops Hair Oil). Revenue is generated through sales to a b...
Bajaj Consumer Care Limited Earnings Call Summary
Earnings Call Date:Oct 14, 2026
(Q2-2027)
| % Change Since: |
Next Earnings Date:Feb 03, 2027
Earnings Call Sentiment Positive
The call was predominantly positive, supported by strong Q2 and H1 revenue, EBITDA, and PAT growth; double-digit Almond Drops unit growth; momentum across Coconut, organized trade, rural markets, international business, and QuickCom; improved growth-portfolio profitability; and tangible distribution expansion through Project Aarohan. The main cautions were raw-material and edible-oil inflation, sequential gross-margin reduction, uncertainty around future margins and demand after pricing actions, a tough Bangladesh market, and no current M&A activity. Highlights significantly outweighed the lowlights.Positive Updates
Strong Q2 and H1 Financial Performance
Q2 revenue was INR 333 crores, up 27% year over year. Q2 EBITDA was INR 83 crores with a 25% EBITDA margin, while PAT was INR 70 crores with a 21% PAT margin. H1 revenue increased 28% to INR 674 crores, H1 EBITDA was INR 167 crores, up 85% over the previous H1, and H1 PAT was INR 141 crores, up 35%.
Negative Updates
Raw Material Cost Volatility Pressured Gross Margins
The quarter experienced continued volatility in key raw material prices due to the West Asia war, edible oil inflation, and the cascading impact of these factors. Gross margin was 59.9% in Q2 and 60.8% for H1, with management noting a sequential reduction in gross margin.
Read all updates
Q2-2027 Updates
Positive
Negative
Strong Q2 and H1 Financial Performance
Q2 revenue was INR 333 crores, up 27% year over year. Q2 EBITDA was INR 83 crores with a 25% EBITDA margin, while PAT was INR 70 crores with a 21% PAT margin. H1 revenue increased 28% to INR 674 crores, H1 EBITDA was INR 167 crores, up 85% over the previous H1, and H1 PAT was INR 141 crores, up 35%.
Read all positive updates
Company Guidance
Management said its aspirations remain unchanged, with FY 2027 expected to deliver high teens growth and the long term targeted at double-digit growth, while it could not guide to next quarter or thereon. In quarter three, it plans another round of price increase and MLH reduction, approximately taking a 5% increase in consumer price, split roughly equally between frontal price increase of 2%-3% and a similar contribution through MLH reductions. Distribution expansion is expected to drive maybe 2-3 percentage point of volume growth; Aarohan 2.0 will expand direct reach in urban by 10% and in rural by more than that over the next six quarters across all 27 states, with another 10% expansion targeted. Management said it wants to reach 75% index on direct distribution, with the journey up to 75% or 80% expected to be fruitful, while gross-margin and margin outcomes remain difficult to predict because the cost environment is volatile.Bajaj Consumer Care Limited Financial Statement Overview
Summary
Income Statement
76
Positive
Balance Sheet
92
Very Positive
Cash Flow
72
Positive
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.07B | 11.65B | 9.65B | 9.68B | 9.49B | 8.67B |
| Gross Profit | 6.44B | 5.49B | 5.23B | 5.25B | 5.09B | 4.78B |
| EBITDA | 3.18B | 2.48B | 1.27B | 2.00B | 1.78B | 2.13B |
| Net Income | 2.51B | 1.90B | 1.25B | 1.55B | 1.39B | 1.70B |
Balance Sheet | ||||||
| Total Assets | 10.69B | 9.45B | 9.01B | 9.84B | 9.24B | 9.31B |
| Cash, Cash Equivalents and Short-Term Investments | 5.27B | 4.06B | 4.53B | 6.30B | 5.91B | 6.24B |
| Total Debt | 134.75M | 157.97M | 41.69M | 87.51M | 92.84M | 0.00 |
| Total Liabilities | 1.71B | 1.90B | 1.53B | 1.53B | 1.35B | 1.22B |
| Stockholders Equity | 8.98B | 7.55B | 7.48B | 8.31B | 7.90B | 8.10B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.87B | 597.23M | 1.12B | 950.41M | 1.18B |
| Operating Cash Flow | 0.00 | 2.20B | 650.98M | 1.16B | 1.01B | 1.29B |
| Investing Cash Flow | 0.00 | -377.39M | 1.55B | 126.42M | 646.06M | 6.91M |
| Financing Cash Flow | 0.00 | -1.96B | -2.12B | -1.20B | -1.63B | -1.24B |
Bajaj Consumer Care Limited Technical Analysis
Negative
551.10
Price Trends
477.43
Negative
523.42
Negative
467.32
Negative
Market Momentum
-32.28
Positive
26.51
Positive
7.10
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:BAJAJCON, the sentiment is Negative. The current price of 551.1 is above the 20-day moving average (MA) of 450.53, above the 50-day MA of 477.43, and above the 200-day MA of 467.32, indicating a bearish trend. The MACD of -32.28 indicates Positive momentum. The RSI at 26.51 is Positive, neither overbought nor oversold. The STOCH value of 7.10 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:BAJAJCON.
Bajaj Consumer Care Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ₹1.04T | 54.87 | ― | 0.45% | 25.00% | 12.83% | |
73 Outperform | ₹48.53B | 19.50 | ― | 3.77% | 28.55% | 92.82% | |
69 Neutral | ₹4.38T | 29.09 | ― | 2.20% | 6.41% | 38.32% | |
65 Neutral | ₹649.27B | 32.88 | ― | 2.25% | 7.40% | 10.63% | |
63 Neutral | ₹144.12B | 57.79 | ― | 0.68% | 21.08% | 237.04% | |
59 Neutral | ₹834.22B | 42.32 | ― | 2.44% | 12.02% | 8.49% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
IN:BAJAJCON
Bajaj Consumer Care Limited
370.10
93.45
33.78%
IN:DABUR
Dabur India Limited
366.00
-113.12
-23.61%
IN:GODREJCP
Godrej Consumer Products Limited
815.10
-281.96
-25.70%
IN:HINDUNILVR
Hindustan Unilever Limited
1,864.00
-521.23
-21.85%
IN:HONASA
Honasa Consumer Limited
442.05
159.36
56.37%
IN:MARICO
Marico Limited
800.75
83.68
11.67%
Bajaj Consumer Care Limited Corporate Events
Bajaj Consumer Care Releases Q2 FY27 Earnings Call Transcript
Oct 21, 2026
Bajaj Consumer Care Limited has notified the stock exchanges that it has released the transcript of its Q2 FY27 earnings conference call held on October 15, 2026.The company has asked BSE and NSE to take the document on record and disseminate it t...
Bajaj Consumer Care to Engage Investors at Nuvama Emerging India CEO Forum
Sep 23, 2026
Bajaj Consumer Care Limited has informed stock exchanges that it will participate in the Nuvama Emerging India CEO Forum, an investor conference to be held on September 28, 2026, at the Grand Hyatt in Mumbai. The company will engage in one-on-one ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.